CD44 is required for two consecutive steps in HGF/c-Met signaling
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 16 (23) , 3074-3086
- https://doi.org/10.1101/gad.242602
Abstract
The tyrosine kinase receptor c-Met and its ligand HGF/SF, ezrin, and splice variants of CD44 have independently been identified as tumor metastasis-associated proteins. We now show that these proteins cooperate. A CD44 isoform containing variant exon v6 sequences is strictly required for c-Met activation by HGF/SF in rat and human carcinoma cells, in established cell lines as well as in primary keratinocytes. CD44v6-deficient tumor cells were unable to activate c-Met unless they were transfected with a CD44v6-bearing isoform. Antibodies to two v6-encoded epitopes inhibited autophosphorylation of c-Met by interfering with the formation of a complex formed by c-Met, CD44v6, and HGF/SF. In addition, signal transduction from activated c-Met to MEK and Erk required the presence of the cytoplasmic tail of CD44 including a binding motif for ERM proteins. This suggests a role for ERM proteins and possibly their link to the cortical actin cytoskeleton in signal transfer.Keywords
This publication has 67 references indexed in Scilit:
- Scatter Factor Receptors are Key Players in a Unique Multistep Program Leading to Invasive GrowthPublished by Wiley ,2007
- A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive GrowthCell, 2001
- CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell MigrationJournal of Biological Chemistry, 2001
- Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-METOncogene, 1999
- Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivoCurrent Biology, 1998
- Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.Genes & Development, 1997
- Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.The Journal of cell biology, 1996
- The Transmembrane Protein-tyrosine Phosphatase LAR Modulates Signaling by Multiple Receptor Tyrosine KinasesJournal of Biological Chemistry, 1996
- Binding of Cell-Surface Expressed CD44 to Hyaluronate Is Dependent on Splicing and Cell TypeBiochemical and Biophysical Research Communications, 1995
- A PCR-based method for the analysis of human CD44 splice products.Genome Research, 1993